Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoke Therapeutics (STOK) Cash from Investing Activities (2022 - 2025)

Stoke Therapeutics has reported Cash from Investing Activities over the past 4 years, most recently at -$61.1 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 7555.56% year-over-year to -$61.1 million; the TTM value through Dec 2025 reached -$186.8 million, down 73.82%, while the annual FY2025 figure was -$186.8 million, 73.82% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$61.1 million at Stoke Therapeutics, down from $9.1 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $67.3 million in Q3 2022 and troughed at -$148.5 million in Q2 2025.
  • A 4-year average of -$14.6 million and a median of $9.5 million in 2024 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: surged 15977.4% in 2023 and later crashed 7555.56% in 2025.
  • Year by year, Cash from Investing Activities stood at $22.5 million in 2022, then tumbled by 34.32% to $14.8 million in 2023, then crashed by 94.46% to $819000.0 in 2024, then crashed by 7555.56% to -$61.1 million in 2025.
  • Business Quant data shows Cash from Investing Activities for STOK at -$61.1 million in Q4 2025, $9.1 million in Q3 2025, and -$148.5 million in Q2 2025.